/THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO
Each LIFE Unit will consist of one common share of the
The LIFE Offering has been structured to take advantage of the listed issuer financing exemption from prospectus requirements (the "Exemption") in Part 5A of National Instrument 45-106 – Prospectus Exemptions ("NI 45-106"), whereby shares issued pursuant to the Exemption are freely tradeable listed equity securities not subject to any hold period (see below). The LIFE Offering will be conducted in all the provinces of
There is an offering document relating to the LIFE Offering (the "Offering Document") that can be accessed under the Company's profile at www.sedarplus.ca and on the Company's website at medbright.ai. Prospective investors should read the Offering Document before making an investment decision.
The net proceeds of the Offering will be used for business development, general working capital, other general corporate purposes, and sales and marketing activities as described in the Offering Document.
The Offering is anticipated to close on or about
This press release shall not constitute an offer to sell or the solicitation of an offer to buy securities in
About
MedBright AI Investments is a capital allocator that invests in diversified industries, including technology, and healthcare. Investments may include equity, debt, or other securities of both public and private companies and control stake acquisitions. MedBright has a focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.
Cautionary Statement Regarding "Forward-Looking" Statements
This news release includes certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this news release, other than statements of historical facts, including statements regarding future estimates, plans, objectives, timing, assumptions or expectations of future performance, including, without limitation, the anticipated closing of the Offering, on the anticipated terms or at all; the anticipated terms of the LIFE Units, the Special Warrants and the Warrants; the anticipated entry by the Company into a warrant indenture with a warrant trustee; the anticipated use of the net proceeds of the Offering; the anticipated receipt of all necessary approvals in respect of the Offering; and the Company's plans to generate returns for its shareholders through its portfolio of investments, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as "intends" or "anticipates", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "should" or "would" or occur.
Forward-looking statements are based on certain material assumptions and analysis made by the Company and the opinions and estimates of management as of the date of this press release, including, among other things, that the Offering will close on the anticipated terms or at all; that the LIFE Units, the Special Warrants and the Warrants will have the anticipated terms; that the Company will enter into a warrant indenture with a warrant trustee; that the Company will use the net proceeds of the Offering as anticipated; that the Company will receive all necessary approvals in respect of the Offering; and that the Company will be able to generate returns for its shareholders. These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or forward-looking information. Important risks that may cause actual results to vary, include, without limitation, the risks that the Offering will not close on the anticipated terms or at all; that the LIFE Units, the Special Warrants and the Warrants will not have the anticipated terms; that the Company will not enter into a warrant indenture with a warrant trustee; that the Company will not use the net proceeds of the Offering as anticipated; that the Company will not receive all necessary approvals in respect of the Offering; and that the Company's portfolio of investments will not generate returns for shareholders.
Although management of the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on such information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statement, forward-looking information or financial out-look that are incorporated by reference herein, except in accordance with applicable securities laws.
Neither the Exchange nor any Market Regulator (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this press release.
SOURCE
© Canada Newswire, source